Cargando…

Longitudinal multi-gene panel assessment of circulating tumor DNA revealed tumor burden and molecular characteristics along treatment course of non-small cell lung cancer

BACKGROUND: Most studies associating circulating tumor DNA (ctDNA) with outcome in lung cancer treatment were either cross-sectional or, if longitudinal, only analyzed a limited number of genes. This study evaluated the potential of utilizing ctDNA profiled by a panel of common cancer genes to monit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ho, Gloria Y. F., Wang, Tao, Kwok, Hoi-Hin, Rasul, Rehana, Peila, Rita, Guzman, Maria, Ip, Mary S. M., Lam, David C. L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653134/ https://www.ncbi.nlm.nih.gov/pubmed/33209609 http://dx.doi.org/10.21037/tlcr-20-675

Ejemplares similares

Panels and models for accurate prediction of tumor mutation burden in tumor samples
por: Martínez-Pérez, Elizabeth, et al.
Publicado: (2021)

Individualized Mutation Detection in Circulating Tumor DNA for Monitoring Colorectal Tumor Burden Using a Cancer-Associated Gene Sequencing Panel
por: Sato, Kei A., et al.
Publicado: (2016)

Circulating Tumor DNA as a Biomarker of Radiographic Tumor Burden in SCLC
por: Smith, Jarrod T., et al.
Publicado: (2020)

Optimizing the evaluation of gene-targeted panels for tumor mutational burden estimation
por: Li, Yawei, et al.
Publicado: (2021)

96. Assessing the Impact of the Meningitis/encephalitis Diagnostic Panel on Antimicrobial Stewardship
por: Garellek, Jonathan, et al.
Publicado: (2020)

A Targeted Gene Panel for Circulating Tumor DNA Sequencing in Neuroblastoma
por: Cimmino, Flora, et al.
Publicado: (2020)

Assessment of tumor mutation burden calculation from gene panel sequencing data
por: Xu, Zhenwu, et al.
Publicado: (2019)

Heterogeneous mutation pattern in tumor tissue and circulating tumor DNA warrants parallel NGS panel testing
por: Guo, Qiaomei, et al.
Publicado: (2018)

Expert panel consensus recommendations on the use of circulating tumor DNA assays for patients with advanced solid tumors
por: Imai, Mitsuho, et al.
Publicado: (2022)

Non-Metastatic Esophageal Adenocarcinoma: Circulating Tumor Cells in the Course of Multimodal Tumor Treatment
por: Kuvendjiska, Jasmina, et al.
Publicado: (2019)

Longitudinal Dynamics of Circulating Tumor Cells and Circulating Tumor DNA for Treatment Monitoring in Metastatic Breast Cancer
por: Gerratana, Lorenzo, et al.
Publicado: (2021)

Influence of low tumor content on tumor mutational burden estimation by whole‐exome sequencing and targeted panel sequencing
por: Zhang, Wenxin, et al.
Publicado: (2021)

Analysis of circulating tumor DNA during checkpoint inhibition in metastatic melanoma using a tumor-agnostic panel
por: Kisistók, Judit, et al.
Publicado: (2023)

Probabilistic Mixture Models Improve Calibration of Panel-derived Tumor Mutational Burden in the Context of both Tumor-normal and Tumor-only Sequencing
por: Anaya, Jordan, et al.
Publicado: (2023)

Tumor mutational burden quantification from targeted gene panels: major advancements and challenges
por: Fancello, Laura, et al.
Publicado: (2019)

Data of ‘Circulating tumor DNA correlates with tumor burden and predicts outcome in pancreatic cancer irrespective of tumor stage’
por: Kirchweger, Patrick, et al.
Publicado: (2022)

SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy
por: Zheng, Xiaobin, et al.
Publicado: (2023)

Direct comparison of circulating tumor DNA sequencing assays with targeted large gene panels
por: Yu, Lizhi, et al.
Publicado: (2022)

Cancer gene panel analysis of cultured circulating tumor cells and primary tumor tissue from patients with breast cancer
por: Hwang, Eunjoo, et al.
Publicado: (2017)

Bring along your friends: Homotypic and heterotypic circulating tumor cell clustering to accelerate metastasis
por: Aceto, Nicola
Publicado: (2020)

Clinical utility of tumor genomic profiling in patients with high plasma circulating tumor DNA burden or metabolically active tumors
por: Zhou, Cathy, et al.
Publicado: (2018)

Designing gene panels for tumor mutational burden estimation: the need to shift from ‘correlation’ to ‘accuracy’
por: Wu, Hao-Xiang, et al.
Publicado: (2019)

Analysis of tumor mutational burden: correlation of five large gene panels with whole exome sequencing
por: Heydt, Carina, et al.
Publicado: (2020)

Breaking the Invisible Barriers: Unleashing the Full Potential of Immune Checkpoint Inhibitors in Oncogene-Driven Lung Adenocarcinoma
por: Kwok, Hoi-Hin, et al.
Publicado: (2023)

Nicotinic Acetylcholine Receptor Subunit α7 Mediates Cigarette Smoke-Induced PD-L1 Expression in Human Bronchial Epithelial Cells
por: Kwok, Hoi-Hin, et al.
Publicado: (2021)

Comparison of RNA Marker Panels for Circulating Tumor Cells and Evaluation of Their Prognostic Relevance in Breast Cancer
por: Welsch, Eva, et al.
Publicado: (2023)

Establishment of a multimarker qPCR panel for the molecular characterization of circulating tumor cells in blood samples of metastatic breast cancer patients during the course of palliative treatment
por: Bredemeier, Maren, et al.
Publicado: (2016)

Glypican-1 is enriched in circulating-exosomes in pancreatic cancer and correlates with tumor burden
por: Frampton, Adam E., et al.
Publicado: (2018)

The Tumor Mutational Burden of Chinese Advanced Cancer Patients Estimated by a 381-cancer-gene Panel
por: Zhuang, Wu, et al.
Publicado: (2018)

A novel panel based on immune infiltration and tumor mutational burden for prognostic prediction in hepatocellular carcinoma
por: Xie, Chan, et al.
Publicado: (2021)

Expression of large tumour suppressor (LATS) kinases modulates chemotherapy response in advanced non-small cell lung cancer
por: Luo, Susan Yang, et al.
Publicado: (2020)

Design and Testing of a Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNA
por: Diefenbach, Russell J., et al.
Publicado: (2020)

A Tetra-Panel of Serum Circulating miRNAs for the Diagnosis of the Four Most Prevalent Tumor Types
por: Pastor-Navarro, Belén, et al.
Publicado: (2020)

A novel virtual barcode strategy for accurate panel-wide variant calling in circulating tumor DNA
por: Wu, Leilei, et al.
Publicado: (2020)

Anchored Multiplex PCR Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNA
por: Diefenbach, Russell J., et al.
Publicado: (2022)

Detectability of Plasma-Derived Circulating Tumor DNA Panel in Patients Undergoing Primary Treatment for Uveal Melanoma
por: Francis, Jasmine H., et al.
Publicado: (2022)

Association of Circulating Tumor DNA (ctDNA) Detection in Metastatic Renal Cell Carcinoma (mRCC) with Tumor Burden
por: Maia, Manuel Caitano, et al.
Publicado: (2017)

Perioperative Circulating Tumor DNA in Colorectal Liver Metastases: Concordance with Metastatic Tissue and Predictive Value for Tumor Burden and Prognosis
por: He, Yiping, et al.
Publicado: (2020)

The interplay between cancer type, panel size and tumor mutational burden threshold in patient selection for cancer immunotherapy
por: Golkaram, Mahdi, et al.
Publicado: (2020)

Tumor Mutational Burden Determined by Panel Sequencing Predicts Survival After Immunotherapy in Patients With Advanced Gastric Cancer
por: Kim, Jinchul, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_04vbdkkdv0q585sd86ndma2jk9